-
1دورية أكاديمية
المؤلفون: Oran, Betül, Ahn, Kwang Woo, Fretham, Caitrin, Beitinjaneh, Amer, Bashey, Asad, Pawarode, Attaphol, Wirk, Baldeep, Scott, Bart L, Savani, Bipin N, Bredeson, Christopher, Weisdorf, Daniel, Marks, David I, Rizzieri, David, Copelan, Edward, Hildebrandt, Gerhard C, Hale, Gregory A, Murthy, Hemant S, Lazarus, Hillard M, Cerny, Jan, Liesveld, Jane L, Yared, Jean A, Yves-Cahn, Jean, Szer, Jeffrey, Verdonck, Leo F, Aljurf, Mahmoud, van der Poel, Marjolein, Litzow, Mark, Kalaycio, Matt, Grunwald, Michael R, Diaz, Miguel Angel, Sabloff, Mitchell, Kharfan-Dabaja, Mohamed A, Majhail, Navneet S, Farhadfar, Nosha, Reshef, Ran, Olsson, Richard F, Gale, Robert Peter, Nakamura, Ryotaro, Seo, Sachiko, Chhabra, Saurabh, Hashmi, Shahrukh, Farhan, Shatha, Ganguly, Siddhartha, Nathan, Sunita, Nishihori, Taiga, Jain, Tania, Agrawal, Vaibhav, Bacher, Ulrike, Popat, Uday, Saber, Wael
المساهمون: Medicine
المصدر: Transplantation and cellular therapy ; 27 ; 11 ; 921.e1 ; 921.e10 ; United States
مصطلحات موضوعية: MDS, Melphalan, Relapse, Survival, Transplantation
العلاقة: Transplantation and Cellular Therapy; https://doi.org/10.1016/j.jtct.2021.08.007Test; Oran B, Ahn KW, Fretham C, Beitinjaneh A, Bashey A, Pawarode A, Wirk B, Scott BL, Savani BN, Bredeson C, Weisdorf D, Marks DI, Rizzieri D, Copelan E, Hildebrandt GC, Hale GA, Murthy HS, Lazarus HM, Cerny J, Liesveld JL, Yared JA, Yves-Cahn J, Szer J, Verdonck LF, Aljurf M, van der Poel M, Litzow M, Kalaycio M, Grunwald MR, Diaz MA, Sabloff M, Kharfan-Dabaja MA, Majhail NS, Farhadfar N, Reshef R, Olsson RF, Gale RP, Nakamura R, Seo S, Chhabra S, Hashmi S, Farhan S, Ganguly S, Nathan S, Nishihori T, Jain T, Agrawal V, Bacher U, Popat U, Saber W. Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes. Transplant Cell Ther. 2021 Nov;27(11):921.e1-921.e10. doi:10.1016/j.jtct.2021.08.007. Epub 2021 Aug 14. PMID: 34403791; PMCID: PMC9562611.; http://hdl.handle.net/20.500.14038/51890Test
الإتاحة: https://doi.org/10.1016/j.jtct.2021.08.007Test
https://doi.org/20.500.14038/51890Test
https://hdl.handle.net/20.500.14038/51890Test -
2دورية أكاديمية
المؤلفون: Oran, Betül, Ahn, Kwang Woo, Fretham, Caitrin, Beitinjaneh, Amer, Bashey, Asad, Pawarode, Attaphol, Wirk, Baldeep, Scott, Bart L., Savani, Bipin N., Bredeson, Christopher, Weisdorf, Daniel, Marks, David I., Rizzieri, David, Copelan, Edward, Hildebrandt, Gerhard C., Hale, Gregory A., Murthy, Hemant S., Lazarus, Hillard M., Cerny, Jan, Liesveld, Jane L., Yared, Jean A., Yves-Cahn, Jean, Szer, Jeffrey, Verdonck, Leo F., Aljur, Mahmoud, van der Poel, Marjolein, Litzow, Mark, Kalaycio, Matt, Grunwald, Michael R., Diaz, Miguel Angel, Sabloff, Mitchell, Kharfan-Dabaja, Mohamed A., Majhail, Navneet S., Farhadfar, Nosha, Reshef, Ran, Olsson, Richard F., Gale, Robert Peter, Nakamura, Ryotaro, Seo, Sachiko, Chhabra, Saurabh, Hashmi, Shahrukh, Farhan, Shatha, Ganguly, Siddhartha, Nathan, Sunita, Nishihori, Taiga, Jain, Tania, Agrawal, Vaibhav, Bacher, Ulrike, Popat, Uday, Saber, Wael
المساهمون: Medicine, School of Medicine
المصدر: PMC
مصطلحات موضوعية: MDS, Melphalan, Relapse, Survival, Transplantation
وصف الملف: application/pdf
العلاقة: Transplantation and Cellular Therapy; Oran B, Ahn KW, Fretham C, et al. Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes. Transplant Cell Ther. 2021;27(11):921.e1-921.e10. doi:10.1016/j.jtct.2021.08.007; https://hdl.handle.net/1805/35894Test
-
3دورية أكاديمية
المؤلفون: Mukherjee, Sudipto1 mukhers2@ccf.org, Boccaccio, Dominic2, Sekeres, Mikkael A.1, Copelan, Edward3
المصدر: Biology of Blood & Marrow Transplantation. Mar2015, Vol. 21 Issue 3, p412-420. 9p.
مصطلحات موضوعية: *MYELODYSPLASTIC syndromes treatment, *MYELODYSPLASTIC syndromes, *MOLECULAR pathology, *HEMATOPOIETIC stem cell transplantation, *HOMOGRAFTS, *CYTOREDUCTIVE surgery, *PROGNOSIS